IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q4 2016 Holdings

Filed 2017-02-13 | 18 holdings | $18.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$18.5M3,608,17197.8%
Loxo Oncology IncCOM548862101$129.4K4,028,9200.7%
Zeltiq Aesthetics IncCOM98933Q108$70.1K1,609,7270.4%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$61.1K2,990,0000.3%
Versartis IncCOM92529L102$37.6K2,524,4650.2%
Viewray Inc.(VRAYQ)COM92672L107$23.4K7,480,8870.1%
Esperion Therapeutics Inc.(ESPR)COM29664W105$20.5K1,637,1250.1%
T2 Biosystems IncCOM89853L104$14.9K2,830,9920.1%
Transenterix Inc.COM NEW89366M201$10.8K8,335,8190.1%
Cidara Therapeutics Inc.COM171757107$10.6K1,021,1480.1%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$10.3K1,804,9330.1%
Paratek Pharmaceuticals IncCOM699374302$7.4K482,6800.0%
Syros Pharmaceuticals, Inc.COM87184Q107$6.2K508,5650.0%
Cempra IncCOM15130J109$3.3K1,193,0600.0%
Intersect ENT IncCOM46071F103$2.7K225,0000.0%
Chimerix Inc.(CMRXEUR)COM16934W106$2.2K472,9430.0%
Pernix Therapeutics Hldgs IncDEBT71426VAK4$625$2,500,0000.0%
Pernix Therapeutics Hldgs inCOM71426V306$407210,0000.0%